Abliva AB (OSTO:ABLI) Total Liabilities : kr10.30 Mil (As of Mar. 2024)

View and export this data going back to 2008. Start your Free Trial

What is Abliva AB Total Liabilities?

Abliva AB's Total Liabilities for the quarter that ended in Mar. 2024 was kr10.30 Mil.

Abliva AB's quarterly Total Liabilities increased from Sep. 2023 (kr13.25 Mil) to Dec. 2023 (kr16.78 Mil) but then declined from Dec. 2023 (kr16.78 Mil) to Mar. 2024 (kr10.30 Mil).

Abliva AB's annual Total Liabilities increased from Dec. 2021 (kr17.39 Mil) to Dec. 2022 (kr19.54 Mil) but then declined from Dec. 2022 (kr19.54 Mil) to Dec. 2023 (kr16.78 Mil).

Abliva AB Total Liabilities Historical Data

The historical data trend for Abliva AB's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abliva AB Total Liabilities Chart

Abliva AB Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

20.70

10.30

17.39

19.54

16.78

Abliva AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															7.64	13.64	13.25	16.78	10.30

Abliva AB Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Abliva AB's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	16.357	+	(0	+	0.424
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	16.78

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	87.499	-	70.718
	=	16.78

Abliva AB's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	9.978	+	(0	+	0.321
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	10.30

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	63.17	-	52.871
	=	10.30

Abliva AB Total Liabilities Related Terms

Thank you for viewing the detailed overview of Abliva AB's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Abliva AB (OSTO:ABLI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abliva AB (OSTO:ABLI) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

NEVPF:USA NTP:Germany

Address

Scheeletorget 1, Medicon Village, Lund, SWE, 223 81

Website

https://www.abliva.com

Abliva AB is a Swedish company that is active in pharmaceutical development. It develops medicines for the treatment of primary mitochondrial diseases. These congenital, rare, and often very severe diseases occur when the cell's energy provider, the mitochondria, does not function properly. The portfolio includes projects at different stages and ranges from the early discovery phase to the clinical phase.

Abliva AB (OSTO:ABLI) Headlines

No Headlines